col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Mary Ann Liebert: Viral Immunology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―23 Pathogenesis of Coronaviruses Through Human Monocytes and Tissue Macrophages Chenghao Huang
2 [GO] 2021―Jul―06 Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2 Martin Krsak, Brian L. Harry, Brent E. Palmer, Carlos Franco-Paredes
3 [GO] 2021―Jun―11 Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19 Mariana Avendaño-Félix, Luis Antonio Ochoa-Ramírez, Rosalío Ramos-Payán, Maribel Aguilar-Medina, Alfredo Ayala-Ham, Horacio Rendón-Aguilar, et al. (+4)
4 [GO] 2021―Jun―08 An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay Haseeb Ahsan, Jong Kyung Sonn, Young Sup Lee, Salman Ul Islam, Saifullah Khan Khalil
5 [GO] 2021―May―21 CD14+HLA-DR+ Cells in Patients May Be a Biomarker Reflecting the Progression of COVID-19 Mengyuan Yang, Zhiyu Liu, Kai Kang, Kaijiang Yu, Changsong Wang
6 [GO] 2021―May―21 Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets Noha A. Kamel, Lamia M. El Wakeel, Khaled M. Aboshanab
7 [GO] 2021―May―17 Herd Immunity Against COVID-19: More Questions Than Answers Rodney S. Russell
8 [GO] 2021―May―13 Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis Anthony R. Mawson, Ashley M. Croft, Federico Gonzalez-Fernandez
9 [GO] 2021―Apr―27 The Effect of SARS-CoV-2 on the Spleen and T Lymphocytes Lixia Xie, Yuanlan Lin, Yushu Deng, Bin Lei
10 [GO] 2021―Mar―19 Serological Evaluation of Human Antibodies of the Immunoglobulin Class A and G Against SARS-CoV-2 in Serum Collected in Newfoundland and Labrador Robert Needle, Laura Gilbert, George Zahariadis, Yang Yu, Hedy Dalton-Kenny, Rodney S. Russell, et al. (+4)
11 [GO] 2021―Feb―24 T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications Juan Camilo Sarmiento-Monroy, Rafael Parra-Medina, Edgar Garavito, Adriana Rojas-Villarraga
12 [GO] 2021―Feb―19 The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses Eleazar Ramírez Hernández, Luis Fernando Hernández-Zimbrón, Nayeli Martínez Zúñiga, Juan José Leal-García, Violeta Ignacio Hernández, Luis Eduardo Ucharima-Corona, et al. (+2)
13 [GO] 2021―Jan―22 Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology Ashutosh Kumar, Sujeet Kumar, Ravi K. Narayan, Chiman Kumari, Vikas Pareek, Pranav Prasoon
14 [GO] 2020―Dec―22 How to Understand Herd Immunity in the Context of COVID-19 Minghao Dong, Feng He, Yu Deng
15 [GO] 2020―Dec―02 Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19 Sumeyye Kazancioglu, Fatma Meric Yilmaz, Aliye Bastug, Arzu Sakallı, Bahadır Orkun Ozbay, Cansu Buyuktarakci, et al. (+2)
16 [GO] 2020―Dec―02 COVID-19 Infection: Data Gaps for Diagnostic Laboratory Preparedness and Tasks on Hand Subrata Biswas, Piyali Ghosh, Debjit Chakraborty, Ananya Chatterjee, Shanta Dutta, Malay Kumar Saha
17 [GO] 2020―Nov―17 Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19 Yang Gao, Changsong Wang, Kai Kang, Yahui Peng, Yunpeng Luo, Haitao Liu, et al. (+3)
18 [GO] 2020―Nov―12 Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-γ as a Novel Antiviral Approach Against COVID-19 Faisal Rasheed Anjum, Sidra Anam, Ghazanfar Abbas, Muhammad Shahid Mahmood, Sajjad ur Rahman, Mohsan Ullah Goraya, et al. (+5)
19 [GO] 2020―Nov―12 COVID-19: Way Forward With Serosurveillance Without Overemphasizing Neutralizing Antibodies Martin Krsak, Andrés F. Henao-Martínez, Carlos Franco-Paredes
20 [GO] 2020―Nov―04 Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons Abdollah Jafarzadeh, Maryam Nemati, Bhaskar Saha, Yashwant D. Bansode, Sara Jafarzadeh
21 [GO] 2020―Oct―05 Letter to the Editor: Toll-Like Receptor Antagonists as a Potential Therapeutic Strategy Against Cytokine Storm in COVID-19-Infected Patients Sadegh Safaei, Masoud Karimi-Googheri
22 [GO] 2020―Oct―05 COVID-19: Between Past and Present Areej M. Assaf, Randa N. Haddadin, Amal A. Akour
23 [GO] 2020―Sep―28 Coronavirus Disease 2019 Vaccine Development: An Overview Riyadi Sumirtanurdin, Melisa Intan Barliana
24 [GO] 2020―Aug―28 Is There a Rationale for Using Bacillus Calmette-Guerin Vaccine in Coronavirus Infection? Nidhi Maheshwari, Ayush Jain
25 [GO] 2020―Jul―02 Review of the SARS-CoV-2 in Wuhan and Analysis as Well as Prediction of Therapeutic Drugs Ruiyi Zhang, Yanmei Tang
26 [GO] 2020―Jun―09 Call for Papers: Special Issue on Coronaviruses Rodney Russell
27 [GO] 2020―May―13 Call for Papers: Special Issue on Coronaviruses Rodney Russell
28 [GO] 2020―Apr―29 B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020 Julia L. Hurwitz
29 [GO] 2020―Apr―27 Issues on Coronavirus Disease 2019 (COVID-19) Pathogenesis José Valter Joaquim Silva Júnior, Thaísa Regina Rocha Lopes, Pablo Sebastian Britto de Oliveira, Rudi Weiblen, Eduardo Furtado Flores
30 [GO] 2020―Apr―16 Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19 Yang Liu, Wenjian Liao, Lagen Wan, Tianxing Xiang, Wei Zhang
31 [GO] 2020―Apr―14 Peter's Paradigm and Pandemic Preparedness Maryna C. Eichelberger
32 [GO] 2020―Apr―06 Call for Papers: Special Issue on Coronaviruses


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.017 sec